KARAGÜZEL, G. 2014. A novel founder mutation of CYP21A2 in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Annual Meeting for the European Society for Pediatric Endocrinology, 18th-20th September, 2014 , (Dublin, Ireland), 3.

KARAGÜZEL, G., (2014). A novel founder mutation of CYP21A2 in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency . Annual Meeting for the European Society for Pediatric Endocrinology, 18th-20th September, 2014 (pp.3). Dublin, Ireland

KARAGÜZEL, GÜLAY. "A novel founder mutation of CYP21A2 in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency," Annual Meeting for the European Society for Pediatric Endocrinology, 18th-20th September, 2014, Dublin, Ireland, 2014

KARAGÜZEL, GÜLAY. "A novel founder mutation of CYP21A2 in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency." Annual Meeting for the European Society for Pediatric Endocrinology, 18th-20th September, 2014 , Dublin, Ireland, pp.3, 2014

KARAGÜZEL, G. (2014) . "A novel founder mutation of CYP21A2 in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency." Annual Meeting for the European Society for Pediatric Endocrinology, 18th-20th September, 2014 , Dublin, Ireland, p.3.

@conferencepaper{conferencepaper, author={GÜLAY KARAGÜZEL}, title={A novel founder mutation of CYP21A2 in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency}, congress name={Annual Meeting for the European Society for Pediatric Endocrinology, 18th-20th September, 2014}, city={Dublin}, country={Ireland}, year={2014}, pages={3} }